{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:08:32Z","timestamp":1788952112528,"version":"build-2803163510"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100027399","name":"ADVANCE","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100027399","id-type":"DOI","asserted-by":"publisher"}]},{"name":"LAA"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>The Watchman device is widely used for left atrial appendage occlusion but may be unsuitable in patients with complex anatomies, resulting in screening failures. The Amulet occluder, with its dual-seal design, may overcome these limitations. The aim of this analysis is to evaluate procedural success, closure, and clinical outcomes of Amulet occluder implantation in patients who failed Watchman screening.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>This analysis from the ADVANCE LAA study included patients ineligible for Watchman (Screen Fail) compared to patients eligible for Amulet and Watchman (Device Eligible). Baseline characteristics, procedural details, cardiac imaging, and clinical events were assessed through 1 year. The safety endpoint composite was a composite of all-cause death, ischaemic stroke, systemic embolism, or device\/procedure-related events requiring open cardiac surgery or major endovascular intervention within hospital discharge or 7 days post-implant. Independent core laboratory and clinical events committee adjudicated imaging and adverse events, respectively. A total of 609 patients underwent Amulet implantation (Screen Fail: n = 97; Device Eligible: n = 512). Screen Fail patients had more complex anatomy and higher CHA2DS2-VASc and HAS-BLED scores. Despite these differences, implant success was high (96.9% vs. 98.0%; P = 0.446). Clinically relevant closure on transoesophageal echocardiography (\u22643\u2005mm peri-device leak) was achieved in \u226597% of patients in both groups at implant and 1\u20133 months. The peri-procedural safety endpoint composite rate was similar in both groups [3.1% vs. 2.7%; OR: 1.14 (0.32, 4.03); P = 0.742]. One-year rates of stroke (1.1% vs. 1.0%), major bleeding (9.6% vs. 6.2%), cardiovascular\/unknown death (2.1% vs. 5.2%), and all-cause death (6.3% vs. 6.6%) were similar between groups (P &amp;gt; 0.05).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Amulet occluder implantation was feasible, safe, and effective in patients with or without failed Watchman screening, providing a viable option for both anatomically simple and complex anatomies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Trial Registration<\/jats:title>\n                    <jats:p>URL https:\/\/clinicaltrials.gov Unique Identifier NCT05997446<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/europace\/euag228","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T11:40:48Z","timestamp":1787658048000},"source":"Crossref","is-referenced-by-count":0,"title":["Outcomes of Amulet occluder implantation following Watchman screen failure in the ADVANCE LAA study: a real-world analysis of procedural success and safety"],"prefix":"10.1093","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1492-2693","authenticated-orcid":false,"given":"Dhanunjaya","family":"Lakkireddy","sequence":"first","affiliation":[{"name":"Kansas City Heart Rhythm Institute and Research Foundation , @ HCA Midwest, 5100 W 100th St, Suite-200, Overland Park, KS 66211, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7027-984X","authenticated-orcid":false,"given":"Jacqueline","family":"Saw","sequence":"additional","affiliation":[{"name":"Vancouver General Hospital , Vancouver, BC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akash","family":"Makkar","sequence":"additional","affiliation":[{"name":"Arizona Heart Arrhythmia Associates , Phoenix AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipak","family":"Shah","sequence":"additional","affiliation":[{"name":"Heart Cardiology Consultants , Southfield, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruby","family":"Satpathy","sequence":"additional","affiliation":[{"name":"Baptist Heart Specialists , Jacksonville, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhamed","family":"Saric","sequence":"additional","affiliation":[{"name":"NYU Langone Health , New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Sharma","sequence":"additional","affiliation":[{"name":"Cardiovascular Medicine , Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Cuoco","sequence":"additional","affiliation":[{"name":"Trident Medical Center , Charleston, SC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7356-2421","authenticated-orcid":false,"given":"Robert","family":"Percell","sequence":"additional","affiliation":[{"name":"Northwestern Medicine , Mchenry, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Manoukian","sequence":"additional","affiliation":[{"name":"Heart Rhythm Associates , Shenandoah, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4247-2163","authenticated-orcid":false,"given":"Ryan","family":"Gage","sequence":"additional","affiliation":[{"name":"Abbott Electrophysiology , Plymouth, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6983-1019","authenticated-orcid":false,"given":"Jordan A","family":"Anderson","sequence":"additional","affiliation":[{"name":"Abbott Electrophysiology , Plymouth, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himanshu","family":"Agarwal","sequence":"additional","affiliation":[{"name":"CHI Creighton University School of Medicine \u2013 Bergan Mercy Hospital , Omaha, NE , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"key":"2026090903520117800_euag228-B1","doi-asserted-by":"crossref","first-page":"e1048","DOI":"10.1016\/j.hrthm.2025.05.048","article-title":"2025 SCAI\/HRS clinical practice guidelines on transcatheter left atrial appendage occlusion","volume":"22","author":"Goldsweig","year":"2025","journal-title":"Heart Rhythm"},{"key":"2026090903520117800_euag228-B2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jacc.2023.08.017","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"83","author":"Joglar","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2026090903520117800_euag228-B3","doi-asserted-by":"crossref","first-page":"euae035","DOI":"10.1093\/europace\/euae035","article-title":"Practical guide on left atrial appendage closure for the non-implanting physician: an international consensus paper","volume":"26","author":"Potpara","year":"2024","journal-title":"Europace"},{"key":"2026090903520117800_euag228-B4","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1111\/jce.16729","article-title":"Outcomes of left atrial appendage occlusion treatment with Amulet after unsuccessful Watchman FLX device: a multicenter observational study","volume":"36","author":"Bagga","year":"2025","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026090903520117800_euag228-B5","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1016\/j.hrthm.2024.05.004","article-title":"Feasibility of Amulet occluder implantation after failed left atrial appendage occlusion attempt: insights from the EMERGE LAA postapproval study","volume":"21","author":"Makkar","year":"2024","journal-title":"Heart Rhythm"},{"key":"2026090903520117800_euag228-B6","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/CIRCULATIONAHA.121.057063","article-title":"Amplatzer Amulet left atrial appendage occluder versus Watchman device for stroke prophylaxis (Amulet IDE): a randomized, controlled trial","volume":"144","author":"Lakkireddy","year":"2021","journal-title":"Circulation"},{"key":"2026090903520117800_euag228-B7","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.jacc.2024.10.101","article-title":"5-year results from the AMPLATZER Amulet left atrial appendage occluder randomized controlled trial","volume":"85","author":"Lakkireddy","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"2026090903520117800_euag228-B8","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jcin.2023.11.027","article-title":"First experience with Amulet in the United States: early insights from EMERGE LAA postapproval study","volume":"17","author":"Alkhouli","year":"2024","journal-title":"JACC Cardiovasc Interv"},{"key":"2026090903520117800_euag228-B9","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.123.013750","article-title":"Outcomes with the WATCHMAN FLX in everyday clinical practice from the NCDR left atrial appendage occlusion registry","volume":"17","author":"Kapadia","year":"2024","journal-title":"Circ Cardiovasc Interv"},{"key":"2026090903520117800_euag228-B10","doi-asserted-by":"crossref","first-page":"euad237","DOI":"10.1093\/europace\/euad237","article-title":"Mechanisms, predictors, and evolution of severe peri-device leaks with two different left atrial appendage occluders","volume":"25","author":"Lakkireddy","year":"2023","journal-title":"Europace"},{"key":"2026090903520117800_euag228-B11","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.026309","article-title":"Patients with larger left atrial appendage orifice presented worse prognosis contributed by acute heart failure after left atrial appendage closure","volume":"11","author":"Ren","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"2026090903520117800_euag228-B12","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.jcin.2025.03.009","article-title":"Finishing the job: utilization of Amulet device for 2 prior incomplete left atrial appendage occlusion","volume":"18","author":"Fram","year":"2025","journal-title":"JACC Cardiovasc Interv"},{"key":"2026090903520117800_euag228-B13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jcin.2023.12.012","article-title":"Amulet occluder implantation in patients with failed prior left atrial appendage occlusion: EMERGE LAA insights","volume":"17","author":"Alkhouli","year":"2024","journal-title":"JACC Cardiovasc Interv"},{"key":"2026090903520117800_euag228-B14","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.jcin.2022.09.001","article-title":"Peridevice leak after transcatheter left atrial appendage occlusion: an analysis of the Amulet IDE trial","volume":"15","author":"Price","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"2026090903520117800_euag228-B15","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/CIRCULATIONAHA.121.057859","article-title":"Amulet or watchman device for percutaneous left atrial appendage closure: primary results of the SWISS-APERO randomized clinical trial","volume":"145","author":"Galea","year":"2022","journal-title":"Circulation"},{"key":"2026090903520117800_euag228-B16","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1016\/j.jcin.2025.09.037","article-title":"Comparative outcomes of intracardiac vs transesophageal echocardiographic guidance for left atrial appendage occlusion: insights from EMERGE LAA postapproval study","volume":"18","author":"Alkhouli","year":"2025","journal-title":"JACC Cardiovasc Interv"},{"key":"2026090903520117800_euag228-B17","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1093\/eurheartj\/ehaa169","article-title":"Left atrial appendage occlusion with the Amplatzer Amulet device: full results of the prospective global observational study","volume":"41","author":"Hildick-Smith","year":"2020","journal-title":"Eur Heart J"},{"key":"2026090903520117800_euag228-B18","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jacep.2022.07.014","article-title":"Incidence, predictors, and clinical outcomes of device-related thrombus in the Amulet IDE trial","volume":"9","author":"Schmidt","year":"2023","journal-title":"JACC Clin Electrophysiol"},{"key":"2026090903520117800_euag228-B19","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jcin.2019.02.003","article-title":"Incidence, characterization, and clinical impact of device-related thrombus following left atrial appendage occlusion in the prospective global AMPLATZER Amulet observational study","volume":"12","author":"Aminian","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"2026090903520117800_euag228-B20","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/j.jcin.2023.05.045","article-title":"Impact of device implant depth after left atrial appendage occlusion","volume":"16","author":"Cepas-Guillen","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"2026090903520117800_euag228-B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacep.2026.03.029","article-title":"Outcomes of left atrial appendage occlusion with a coated device: primary analysis of HEAL-LAA","author":"Kanj","year":"2026","journal-title":"JACC Clin Electrophysiol"},{"key":"2026090903520117800_euag228-B22","first-page":"3959","article-title":"Potential of a novel large left atrial appendage closure device: short-term outcomes of the WATCHMAN FLX Pro 40-mm versus 35-mm","volume":"106","author":"Chatani","year":"2025","journal-title":"Catheter Cardiovasc Interv"}],"container-title":["Europace"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/europace\/advance-article-pdf\/doi\/10.1093\/europace\/euag228\/70797424\/euag228.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/28\/9\/euag228\/70797424\/euag228.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/28\/9\/euag228\/70797424\/euag228.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:11:26Z","timestamp":1788948686000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/doi\/10.1093\/europace\/euag228\/8770977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,2]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euag228","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,8,26]]},"article-number":"euag228"}}